Literature DB >> 2747632

The human cytochrome Cyp1A2 gene contains regulatory elements responsive to 3-methylcholanthrene.

L C Quattrochi1, R H Tukey.   

Abstract

The regulation of the human cytochrome Cyp1A2 gene by 3-methylcholanthrene was studied through the transfection of 5'-flanking sequences into human cells. The Cyp1A2 promoter sequence and 3700 bases 5' to the cap site were linked to the procaryotic chloramphenicol acetyltransferase gene. Transfection of this construct into HepG2 cells generated a 2-3-fold increase in Cyp1A2-directed chloramphenicol acetyltransferase activity when the cells were treated with 3-methylcholanthrene. Deletion of flanking sequence to -1079 resulted in a loss of 3-methylcholanthrene-induced chloramphenicol acetyltransferase activity. When 5'-flanking sequences of the Cyp1A2 gene were inserted into a plasmid containing the chloramphenicol acetyltransferase gene under control of the simian virus 40 promoter, 3-methylcholanthrene-enhanced chloramphenicol acetyltransferase activity was observed. The strongest 3-methylcholanthrene-induced chloramphenicol acetyltransferase activity, a 4-fold increase, was observed for a DNA fragment located at -3202 to -1595. When this Cyp1A2 responsive element was transfected into human breast carcinoma MCF-7 cells, 3-methylcholanthrene did not stimulate chloramphenicol acetyltransferase activity. In comparison, when a DNA fragment that contained a copy of the human Cyp1A1 xenobiotic-responsive element was analyzed for enhancer activity, 3-methylcholanthrene initiated chloramphenicol acetyltransferase activity in both HepG2 cells and MCF-7 cells. These results suggest that the 3-methylcholanthrene-responsive Cyp1A2 element may be regulated in a tissue-specific manner.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2747632

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  11 in total

1.  A population and family study of CYP1A2 using caffeine urinary metabolites.

Authors:  A Catteau; Y C Bechtel; N Poisson; P R Bechtel; C Bonaïti-Pellie
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 2.  Drug interactions with tobacco smoking. An update.

Authors:  S Zevin; N L Benowitz
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

3.  Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells.

Authors:  V Krishnan; W Porter; M Santostefano; X Wang; S Safe
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

Review 4.  The aryl hydrocarbon receptor complex and the control of gene expression.

Authors:  Timothy V Beischlag; J Luis Morales; Brett D Hollingshead; Gary H Perdew
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2008       Impact factor: 1.807

5.  The gut-enriched Krüppel-like factor suppresses the activity of the CYP1A1 promoter in an Sp1-dependent fashion.

Authors:  W Zhang; J M Shields; K Sogawa; Y Fujii-Kuriyama; V W Yang
Journal:  J Biol Chem       Date:  1998-07-10       Impact factor: 5.157

Review 6.  P450 enzymes. Inhibition mechanisms, genetic regulation and effects of liver disease.

Authors:  M Murray
Journal:  Clin Pharmacokinet       Date:  1992-08       Impact factor: 6.447

7.  Analysis of human CYP1A1 and CYP1A2 genes and their shared bidirectional promoter in eight world populations.

Authors:  Lucia F Jorge-Nebert; Zhengwen Jiang; Ranajit Chakraborty; Joanna Watson; Li Jin; Stephen T McGarvey; Ranjan Deka; Daniel W Nebert
Journal:  Hum Mutat       Date:  2010-01       Impact factor: 4.878

Review 8.  Cellular responses to oxidative stress: the [Ah] gene battery as a paradigm.

Authors:  D W Nebert; D D Petersen; A J Fornace
Journal:  Environ Health Perspect       Date:  1990-08       Impact factor: 9.031

Review 9.  P450 and human cancer.

Authors:  K Kawajiri; Y Fujii-Kuriyama
Journal:  Jpn J Cancer Res       Date:  1991-12

10.  CYP1A2 polymorphism and theophylline clearance in Korean non-smoking asthmatics.

Authors:  Eun-Young Yim; Hye-Ryun Kang; Jae-Woo Jung; Seong-Wook Sohn; Sang-Heon Cho
Journal:  Asia Pac Allergy       Date:  2013-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.